American Well Corp (AMWL)

Currency in USD
11.060
-0.140(-1.25%)
Real-time Data·
AMWL is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
11.01011.230
52 wk Range
3.71015.160
Key Statistics
Prev. Close
11.2
Open
11.21
Day's Range
11.01-11.23
52 wk Range
3.71-15.16
Volume
8.51K
Average Volume (3m)
110.86K
1-Year Change
175.1244%
Book Value / Share
12.44
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
AMWL Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
13.600
Upside
+22.97%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales decline in the current year

American Well Corp News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Analyst Ratings

1 Buy
6 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 13.600
(+22.97% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
TD Cowen
Hold13.00+17.54%12.00MaintainNov 04, 2026
Wells Fargo
Buy18.00+62.75%16.00MaintainNov 04, 2026
Stifel
Hold12.00+8.50%11.00MaintainNov 04, 2026
Truist Securities
Hold12.00+8.50%7.50MaintainAug 13, 2026
Stifel
Hold11.00-0.54%6.50MaintainAug 05, 2026

American Well Corp Earnings Call Summary for Q3/2026

  • Amwell beat Q3 estimates with adjusted loss of $0.67/share vs. $0.78 expected; revenue of $49M topped $47.3M forecast, marking ninth straight beat.
  • Adjusted EBITDA loss narrowed to $3.6M from $12.7M YoY; company raised FY26 revenue guidance to $204-206M and expects Q4 EBITDA breakeven to positive.
  • Revenue declined 12.9% YoY to $49M due to portfolio changes and churn, but management expects Q4 positive cash flow and adjusted EBITDA profitability.
  • Company pivoting to unified digital health platform strategy, emphasizing engagement and outcomes over access; government contracts with VA and DHA key to 2027 growth.
  • Shares rose 4.2% to $13.05 after hours; cash position remains strong at $181M with no debt, supporting transition to profitability and platform expansion.
Last Updated: 11/04/2026, 07:02 AM
Read Full Transcript

Earnings

Latest Release
Nov 03, 2026
EPS / Forecast
-0.67 / -0.78
Revenue / Forecast
48.99M / 47.29M
EPS Revisions
Last 90 days

AMWL Income Statement

Compare AMWL to Peers and Sector

Metrics to compare
AMWL
Peers
Sector
Relationship
P/E Ratio
−3.4x4.3x−0.2x
PEG Ratio
−0.060.000.00
Price/Book
0.9x2.2x2.6x
Price / LTM Sales
0.9x1.1x2.7x
Upside (Analyst Target)
21.2%29.8%68.5%
Fair Value Upside
Unlock32.2%11.5%Unlock

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Amwell Platform, a cloud-based enablement platform, digitally enables a scalable healthcare experience across all care settings; Amwell Carepoint, a device enable healthcare providers to leverage proprietary carts and transform existing tablets and TVs into digital access points in clinical settings; Amwell Converge, a platform and wraparound services of digital care into the in-person, automated, and virtual care settings; and Behavioral Health, a platform that offer students and faculty the right level of care. It also provides specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care for patients and members; Amwell Medical Group network services consisting of primary and urgent care, behavioral health therapy, lactation counseling, and nutrition services. Further, it provides professional services to facilitate implementation, workflow design, systems integration, and service expansion for its products, as well as patient and provider engagement services. The company sells its products through field sales professionals, channel partners, and value-added resellers. It serves providers, payers, and the government, as well as the higher education sector. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
1.16M6.71%13.10M
Other Institutional Investors
6.97M40.49%79.07M
Public Companies & Retail Investors
9.09M52.80%103.11M
Total
17.22M100.00%195.28M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Senvest Management, LLC7.72%1,329,05715,072
Morgan Stanley7.42%1,278,42914,497

People Also Watch

217.94
ALAB
+3.00%
124.29
CRDO
+0.27%
555.74
LITE
-0.76%
347.20
VLO
-4.56%
52.30
MXL
+1.71%

FAQ

What Is the American Well (AMWL) Stock Price Today?

The American Well stock price today is 11.060 USD.

What Stock Exchange Does American Well Trade On?

American Well is listed and trades on the New York Stock Exchange.

What Is the Stock Symbol for American Well?

The stock symbol for American Well is "AMWL."

What Is the American Well Market Cap?

As of today, American Well market cap is 190.460M USD.

What Is American Well's Earnings Per Share (TTM)?

The American Well EPS (TTM) is -3.42.

When Is the Next American Well Earnings Date?

American Well will release its next earnings report on Feb 17, 2027.

From a Technical Analysis Perspective, Is AMWL a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has American Well Stock Split?

American Well has split 1 times.

How Many Employees Does American Well Have?

American Well has 562 employees.

What is the current trading status of American Well (AMWL)?

As of Nov 18, 2026, American Well (AMWL) is trading at a price of 11.060 USD, with a previous close of 11.200 USD. The stock has fluctuated within a day range of 11.010 USD to 11.230 USD, while its 52-week range spans from 3.710 USD to 15.160 USD.

What Is American Well (AMWL) Price Target According to Analysts?

The average 12-month price target for American Well is 13.600 USD, with a high estimate of 18 USD and a low estimate of 12 USD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Neutral. The stock has an +22.97% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.